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Abstract 
Review on t(11;12)(p15;q13), with data on clinics, 
and the genes involved. 
Keywords 
Chromosome 11; Chromosome 12; NUP98; 
HOXC11; HOXC13; Acute myeloid leukemia; 
Therapy-related myeloid neoplasms 
Identity 
t(11;12)(p15;q13) G- banding - Courtesy Melanie Zenger 
and Claudia Haferlach.  
Note 
t(11;12)(p15;q13) with NUP98 and HOXC11 
involvement has been described in 4 cases 
(Taketani et al., 2002; Gu et al., 2003), and with 
NUP98 and HOXC13 involvement in 3 additional 
cases (La Starza et al., 2003; Panagopoulos et al., 
2003; Tosic et al., 2009) 
Clinics and pathology 
To be noted that NUP98 gene was found rearranged 
but HOXC genes were not tested or neither NUP98 
nor HOX genes were tested in 5 cases (Roulston et 
al., 1998; and Kobzev et al., 2004 are identical 
cases), all of which were treatment-related MDS or 
AML (t-MDS or t-AML): a 9 mths old boy, 3 female 
patients aged 39 yrs, 41 yrs and 55 yrs, and one other 
male patient (Roulston et al., 1998; Nishiyama et al., 
1999; Wong et al., 1998; Masuya et al., 2002; 
Kobzev et al., 2004; Schmidt-Hieber et al., 2010). 
Previous diseases were Hodgkin's disease in 2 cases, 
AML and breast cancer in one case each.  
As noted by La Starza et al., 2009, a NUP98-positive 
acute myeloid leukemia with a t(11;12)(p15;q13) 
can occur without HOXC cluster gene involvement. 
Disease 
All the 7 cases with NUP98/HOXC hybrid gene 
were de novo acute myeloid leukemia: one AML 
without maturation (M1), four AML with maturation 
(M2), one acute myelomonocytic leukaemia (M4) 
and one acute monoblastic/monocytic leukaemia 
(M5b). 
Epidemiology 
Sex ratio was 2M/2F in HOXC11 cases and 0M/3F 
in HOXC13 cases; more cases are needed to 
determine if this discrepancy is 
coincidental/stochastic. Patients were aged 14, 22, 
40 and 41 yrs in HOXC11 cases and 47, 57, 59 yrs 
in HOXC13 cases 
Prognosis 
Two cases were in complete remission (5 mths+, 
NA), and four cases were reported to have died (8 
mths, 8mths, 19 mths, NA). 
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Cytogenetics 
Cytogenetics morphological 
The t(11;12)(p15;q13) was the sole abnormality in 
all the 7 cases with NUP98/HOXC hybrid gene 
ascertained. In the 5 cases of therapy-related 
leukemia without ascertainment of a NUP98/HOXC 
hybrid gene, the t(11;12)(p15;q13) was the sole 
abnormality in 2 cases, and additional abnormalities 
were found: a t(17;21)(q11;q22) with RUNX1 
rearrangement in 1 case, a +21 in 1 case and a del(7q) 
and other abnormalities in 1 case. 
Genes involved and 
proteins 
NUP98 (nucleoporin 98 kDa) 
Location 
11p15.4 
DNA/RNA 
Alternate splicings 
Protein 
920 amino acids (aa) and other ioforms; NUP98 
belongs to the nucleoporin gene family and encodes 
a 186 kDa precursor protein that undergoes 
autoproteolytic cleavage to produce a 98 kDa and 96 
kDa nucleoporins. The 98 kDa nucleoporin contains 
a Gly-Leu-Phe-Gly (GLFG and FG) repeat in N-
term, a GLEBS-like motif (which binds RAE1), and 
a RNA binding motif in C-term. NUP98 is involved 
in nuclear import/export, mitotic progression, and 
regulation of gene expression (Duheron and 
Fahrenkrog, 2015). 
HOXC11 
Location 
12q13.13; Starts at 53973126 and ends at 53976419 
bp from pter (according to hg38-Dec_2013) 
DNA/RNA 
915 nucleotids (nt), 2 exons 
Protein 
304 aa; the protein localizes in the nucleus; 
sequence-specific transcription factor which 
contains a homeodomain with helix-turn-helix 
(HTH) motif in aa 233 to 289.  
Part of the Hox clusters.  
There is a timing mechanism to synchronize Hox 
gene expression during embryogenesis ("Hox 
clock").  
HOX genes regulates the expression of genes that are 
implicated during embryogenesis (anterior-posterior 
patterning and limbs developments).  
HOX genes are also expressed in adult tissues 
(review in Deschamps and Duboule, 2017). 
HOXC13 
Location 
12q13.13; Starts at 53938792 and ends at 53946544 
bp from pter (according to hg19-Feb_2009)  
Note 
HOXC13 starts 37627 nt after the end of HOXC11. 
DNA/RNA 
993 nt, 2 exons 
Protein 
330 aa; the protein localizes in the nucleus; 
sequence-specific transcription factor which 
contains a homeodomain with helix-turn-helix 
(HTH) motif in aa 260 to 319.  
Part of the Hox clusters.  
There is a timing mechanism to synchronize Hox 
gene expression during embryogenesis ("Hox 
clock").  
HOX genes regulates the expression of genes that are 
implicated during embryogenesis (anterior-posterior 
patterning and limbs developments).  
HOX genes are also expressed in adult tissues 
(review in Deschamps and Duboule, 2017). 
Result of the chromosomal 
anomaly 
Hybrid gene 
Description 
The NUP98 breakpoint was between exon 11 and 12 
in three HOXC11 cases (Gu et al., 2003), and 
between exon 14 and 15 in the other HOXC11 case 
(Taketani et al., 2002). It was found between exon 
15 and 16 in two HOXC13 cases (La Starza et al., 
2003; Panagopoulos et al., 2003). The HOXC11 
breakpoint was between exon 1 and 2 (Gu et al., 
2003), or in exon 1 (Taketani et al., 2002). The 
HOXC13 breakpoint was between exon 1 and 2 (La 
Starza et al., 2003; Panagopoulos et al., 2003). 
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Fusion protein 
Description 
fuses the N-term NUP98 to the C-term of HOXC11 
or HOXC13. This correspond to 469 aa or 628 aa 
from NUP98 in the HOXC11 cases and 715 aa in the 
HOXC13 cases fused to 77 aa from HOX11 (Gu et 
al., 2003), or 120 aa from HOX13 (Taketani et al., 
2002). 
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